Chul Min Park

1.7k total citations
95 papers, 1.3k citations indexed

About

Chul Min Park is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Chul Min Park has authored 95 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 18 papers in Organic Chemistry and 13 papers in Infectious Diseases. Recurrent topics in Chul Min Park's work include SARS-CoV-2 and COVID-19 Research (8 papers), Blood Coagulation and Thrombosis Mechanisms (5 papers) and Computational Drug Discovery Methods (5 papers). Chul Min Park is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (8 papers), Blood Coagulation and Thrombosis Mechanisms (5 papers) and Computational Drug Discovery Methods (5 papers). Chul Min Park collaborates with scholars based in South Korea, United States and Japan. Chul Min Park's co-authors include Sung Bae Lee, Sung‐Ho Kang, Dong Young Rhyu, Churl Min Seong, Joo‐Hack Youn, Kyung-Ae Kim, Tae Rin Oh, Jin Sun Kim, Hunseung Kang and Seungtaek Kim and has published in prestigious journals such as Journal of the American Chemical Society, SHILAP Revista de lepidopterología and Journal of Hazardous Materials.

In The Last Decade

Chul Min Park

90 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chul Min Park South Korea 20 585 347 240 141 103 95 1.3k
Benjamin M. Johnson United States 19 407 0.7× 586 1.7× 125 0.5× 66 0.5× 89 0.9× 41 1.5k
Catherine H. Kaschula South Africa 18 447 0.8× 660 1.9× 96 0.4× 337 2.4× 79 0.8× 37 1.8k
Yasuo Nagaoka Japan 27 857 1.5× 770 2.2× 204 0.8× 124 0.9× 177 1.7× 89 1.9k
Kirandeep Kaur India 12 790 1.4× 415 1.2× 80 0.3× 66 0.5× 50 0.5× 40 1.3k
Abhishek Das India 15 242 0.4× 276 0.8× 96 0.4× 128 0.9× 68 0.7× 29 1.2k
Bruno Tasso Italy 24 901 1.5× 587 1.7× 97 0.4× 51 0.4× 207 2.0× 63 1.7k
Mona Salimi Iran 19 303 0.5× 426 1.2× 76 0.3× 120 0.9× 106 1.0× 80 1.1k
Rosanna Filosa Italy 30 732 1.3× 796 2.3× 61 0.3× 125 0.9× 272 2.6× 83 2.4k
Magna Suzana Alexandre‐Moreira Brazil 23 450 0.8× 412 1.2× 75 0.3× 307 2.2× 145 1.4× 98 1.7k
Yogita Bansal India 16 1.4k 2.4× 560 1.6× 67 0.3× 110 0.8× 312 3.0× 35 2.2k

Countries citing papers authored by Chul Min Park

Since Specialization
Citations

This map shows the geographic impact of Chul Min Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chul Min Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chul Min Park more than expected).

Fields of papers citing papers by Chul Min Park

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chul Min Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chul Min Park. The network helps show where Chul Min Park may publish in the future.

Co-authorship network of co-authors of Chul Min Park

This figure shows the co-authorship network connecting the top 25 collaborators of Chul Min Park. A scholar is included among the top collaborators of Chul Min Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chul Min Park. Chul Min Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Ko, Meehyun, Sangeun Jeon, Min Seong Jang, et al.. (2023). Novel SARS‐CoV‐2 entry inhibitors, 2‐anilinoquinazolin‐4(3H)‐one derivatives, show potency as SARS‐CoV‐2 antivirals in a human ACE2 transgenic mouse model. Journal of Medical Virology. 95(6). e28863–e28863. 1 indexed citations
4.
Park, Chul Min, et al.. (2023). Subcritical water extraction of Gracilaria chorda abbreviates lipid accumulation and obesity-induced inflammation. ALGAE. 38(1). 81–92. 5 indexed citations
5.
Kim, Jinhee, Yoon Cho, Hae‐Bin Park, et al.. (2023). Repeated intratracheal instillation of whole‐cigarette smoke condensate to assess lung damage in a rat model. Environmental Toxicology. 39(4). 2304–2315. 1 indexed citations
6.
7.
Jeon, Sangeun, Min Seong Jang, Seungtaek Kim, et al.. (2022). Optimization of 2-Aminoquinazolin-4-(3H)-one Derivatives as Potent Inhibitors of SARS-CoV-2: Improved Synthesis and Pharmacokinetic Properties. Pharmaceuticals. 15(7). 831–831. 7 indexed citations
8.
Lee, Jun Young, Sangeun Jeon, Sunoh Kwon, et al.. (2020). Discovery of cyclic sulfonamide derivatives as potent inhibitors of SARS-CoV-2. Bioorganic & Medicinal Chemistry Letters. 31. 127667–127667. 26 indexed citations
9.
Sharma, Bhesh Raj, Chul Min Park, Hyeon‐A Kim, Hyun Jung Kim, & Dong Young Rhyu. (2019). Tinospora cordifolia preserves pancreatic beta cells and enhances glucose uptake in adipocytes to regulate glucose metabolism in diabetic rats. Phytotherapy Research. 33(10). 2765–2774. 18 indexed citations
10.
Oh, Jisun, et al.. (2018). Novel (1E,3E,5E)-1,6-bis(Substituted phenyl)hexa-1,3,5-triene Analogs Inhibit Melanogenesis in B16F10 Cells and Zebrafish. International Journal of Molecular Sciences. 19(4). 1067–1067. 10 indexed citations
11.
Kawasaki, Yuki, Chul Min Park, Tomohiro Tanaka, et al.. (2016). Feedback control of ErbB2 via ERK-mediated phosphorylation of a conserved threonine in the juxtamembrane domain. Scientific Reports. 6(1). 31502–31502. 21 indexed citations
12.
Park, Sung Yong, et al.. (2014). Brain abscess due to odontogenic infection. 40(3). 147–151. 7 indexed citations
13.
Park, Chul Min, et al.. (2010). 1-(Arylsulfonyl)-2,3-dihydro-1H-quinolin-4-one derivatives as 5-HT6 serotonin receptor ligands. Bioorganic & Medicinal Chemistry Letters. 21(2). 698–703. 12 indexed citations
14.
Park, Hyewon, Chul Min Park, Sung Eun Kim, et al.. (2009). Reversible right heart failure and variant angina associated with hyperthyroidism. The Korean Journal of Internal Medicine. 76(5). 584–588. 1 indexed citations
15.
Park, Jeong Su, Chul Min Park, Ho Eun Chang, et al.. (2008). Evaluation of the Performance of the DG Gel Test for Unexpected Antibody Screening and Identification. The Korean Journal of Blood Transfusion. 19(1). 49–56. 2 indexed citations
16.
Park, Chul Min, et al.. (2008). A case of displacement of intrauterine device into abdominal cavity by uterine perforation in early pregnancy. Obstetrics & Gynecology Science. 51(2). 256–260. 1 indexed citations
17.
Park, Chul Min, Woon Geon Shin, Kyung‐Wook Hong, et al.. (2008). Arteriovenous Malformation Causing Ileocecal Variceal Bleeding in Liver Cirrhosis: Case Report and Review of the Literature. Gut and Liver. 2(1). 54–58. 5 indexed citations
18.
Park, Chul Min, et al.. (2007). Determination of the RhC/c Blood Group by Polymerase Chain Reaction with Sequence-specific Primers of the Intron 2 Insert of the RHCE Gene. The Korean Journal of Blood Transfusion. 18(3). 138–144. 1 indexed citations
19.
Hong, Kyung‐Wook, et al.. (2007). A Case of Spontaneous Splenic Rupture in Vivax Malaria. Infection and Chemotherapy. 39(5). 274–276. 5 indexed citations
20.
Seong, Churl Min, et al.. (2007). Discovery of 3-aryl-3-methyl-1H-quinoline-2,4-diones as a new class of selective 5-HT6 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 18(2). 738–743. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Benjamin M. Johnson Breakdown of academic impact, for papers by Catherine H. Kaschula Breakdown of academic impact, for papers by Yasuo Nagaoka Breakdown of academic impact, for papers by Kirandeep Kaur Breakdown of academic impact, for papers by Abhishek Das Breakdown of academic impact, for papers by Bruno Tasso Breakdown of academic impact, for papers by Mona Salimi Breakdown of academic impact, for papers by Rosanna Filosa Breakdown of academic impact, for papers by Magna Suzana Alexandre‐Moreira Breakdown of academic impact, for papers by Yogita Bansal
Rankless by CCL
2026